Todd P. Branning

Companies

• NeuBase Therapeutics, Inc.Chief financial officer Jan 10, 2022 to Mar 17, 2023¹
• Phathom Pharmaceuticals, Inc.Chief financial officer Jul 13, 2020 to Jan 29, 2021²
• Amneal Pharmaceuticals, Inc.Chief financial officer Jan 23, 2019 to Mar 2, 2020³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NTNeuBase Therapeutics, Inc.84,200 shares⁴Mar 16, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 16, 2023Granted 54,200 shares of NeuBase Therapeutics, Inc.⁴
• Mar 18, 2022Bought 10,000 shares at $1.81 of NeuBase Therapeutics, Inc.⁵
• Mar 17, 2022Bought 10,000 shares at $1.74 of NeuBase Therapeutics, Inc.⁶
• Mar 16, 2022Bought 10,000 shares at $1.62 of NeuBase Therapeutics, Inc.⁶